+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Deep Brain Stimulation in Parkinson's Disease - Global Market Outlook (2019-2027)

  • ID: 5157737
  • Report
  • August 2020
  • Region: Global
  • 192 pages
  • Stratistics Market Research Consulting Pvt Ltd
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott
  • Beijing PINS Medical Co
  • Medtronic
  • Neuronetics Inc.
  • NeuroPace Inc.
  • Nevro Corporation
  • MORE
According to the report, the Global Deep brain Stimulation in Parkinson's Disease Market accounted for $678.89 million in 2019 and is expected to reach $1,509.07 million by 2027, growing at a CAGR of 10.5% during the forecast period.

Increasing incidence of neurological disorders, such as Parkinson’s disease (PD) and supportive government policies and laws of the countries are the major factors driving the market growth. However, a surgical side effect is restraining the market growth.

Deep brain stimulation (DBS) is a neurosurgical procedure involving the placement of a medical device called a neurostimulator (sometimes referred to as a "brain pacemaker"), which sends electrical impulses, through implanted electrodes, to specific targets in the brain. DBS is used to manage some of the symptoms of Parkinson's Disease that cannot be adequately controlled with medications. It is recommended for people who have PD with motor fluctuations and tremor inadequately controlled by medication, or to those who are intolerant to medication, as long as they do not have severe neuropsychiatric problems.

Based on End-user, the ambulatory surgical centers (ASCs) segment is likely to have a huge demand due to several advantages offered by ASCs, such as shorter procedure time and same-day discharge as compared to the hospitals. Moreover, most of the neurosurgeries can now be performed at ASCs as surgical procedures turn out to be more advanced and less invasive. By geography, North America is going to have a lucrative growth during the forecast period due to increase in prevalence of psychological disorders, rise in awareness about treatments, availability of highly skilled physicians, and presence of well-established healthcare facilities. Furthermore, rising adoption of technologically advanced medical devices and rise in the demand for minimally invasive procedures are expected to boost the growth of DBS devices market in this region.

Some of the key players profiled in the Deep brain Stimulation in Parkinson's Disease Market include Abbott, Aleva Neurotherapeutics SA, beijing PINS Medical Co, boston Scientific Corporation, Functional Neuromodulation Ltd., Medtronic, Neuronetics Inc., NeuroPace Inc and Nevro Corporation.

Products Covered:
  • Dual Channel Deep brain Stimulator
  • Single Channel Deep brain Stimulator
End-users Covered:
  • Ambulatory Surgical Centers (ASCs)
  • Hospitals
  • Neurology Clinics
  • Research Centers
Regions Covered:

North America
  • US
  • Canada
  • Mexico
Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia-Pacific
South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa
What the report offers:
  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and Recommendations)
  • Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements
Free Customization Offerings

Purchasers of this report will be entitled to receive one of the following free customization options:

1. Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
2. Regional Segmentation
  • Market estimations, forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
3. Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott
  • Beijing PINS Medical Co
  • Medtronic
  • Neuronetics Inc.
  • NeuroPace Inc.
  • Nevro Corporation
  • MORE
1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End-user Analysis
3.8 Emerging Markets
3.9 Impact of COVID-19

4 Porters Five Forces Analysis
4.1 Bargaining Power of Suppliers
4.2 Bargaining Power of Buyers
4.3 Threat of Substitutes
4.4 Threat of New Entrants
4.5 Competitive Rivalry

5 Global Deep Brain Stimulation in Parkinson's Disease Market, By Product
5.1 Introduction
5.2 Dual Channel Deep Brain Stimulator
5.3 Single Channel Deep Brain Stimulator

6 Global Deep Brain Stimulation in Parkinson's Disease Market, By End-user
6.1 Introduction
6.2 Ambulatory Surgical Centers (ASCs)
6.3 Hospitals
6.4 Neurology Clinics
6.5 Research Centers

7 Global Deep Brain Stimulation in Parkinson's Disease Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia-Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia-Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa

8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launches
8.4 Expansions
8.5 Other Key Strategies

9 Company Profiling
9.1 Abbott
9.2 Aleva Neurotherapeutics SA
9.3 Beijing PINS Medical Co
9.4 Boston Scientific Corporation
9.5 Functional Neuromodulation Ltd.
9.6 Medtronic
9.7 Neuronetics Inc.
9.8 NeuroPace Inc.
9.9 Nevro Corporation

List of Tables
Table 1 Global Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Region (2018-2027) ($MN)
Table 2 Global Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Product (2018-2027) ($MN)
Table 3 Global Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Dual Channel Deep Brain Stimulator (2018-2027) ($MN)
Table 4 Global Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Single Channel Deep Brain Stimulator (2018-2027) ($MN)
Table 5 Global Deep Brain Stimulation in Parkinson's Disease Market Outlook, By End-user (2018-2027) ($MN)
Table 6 Global Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Ambulatory Surgical Centers (ASCs) (2018-2027) ($MN)
Table 7 Global Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Hospitals (2018-2027) ($MN)
Table 8 Global Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Neurology Clinics (2018-2027) ($MN)
Table 9 Global Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Research Centers (2018-2027) ($MN)
Table 10 North America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Country (2018-2027) ($MN)
Table 11 North America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Product (2018-2027) ($MN)
Table 12 North America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Dual Channel Deep Brain Stimulator (2018-2027) ($MN)
Table 13 North America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Single Channel Deep Brain Stimulator (2018-2027) ($MN)
Table 14 North America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By End-user (2018-2027) ($MN)
Table 15 North America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Ambulatory Surgical Centers (ASCs) (2018-2027) ($MN)
Table 16 North America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Hospitals (2018-2027) ($MN)
Table 17 North America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Neurology Clinics (2018-2027) ($MN)
Table 18 North America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Research Centers (2018-2027) ($MN)
Table 19 Europe Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Country (2018-2027) ($MN)
Table 20 Europe Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Product (2018-2027) ($MN)
Table 21 Europe Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Dual Channel Deep Brain Stimulator (2018-2027) ($MN)
Table 22 Europe Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Single Channel Deep Brain Stimulator (2018-2027) ($MN)
Table 23 Europe Deep Brain Stimulation in Parkinson's Disease Market Outlook, By End-user (2018-2027) ($MN)
Table 24 Europe Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Ambulatory Surgical Centers (ASCs) (2018-2027) ($MN)
Table 25 Europe Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Hospitals (2018-2027) ($MN)
Table 26 Europe Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Neurology Clinics (2018-2027) ($MN)
Table 27 Europe Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Research Centers (2018-2027) ($MN)
Table 28 Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Country (2018-2027) ($MN)
Table 29 Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Product (2018-2027) ($MN)
Table 30 Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Dual Channel Deep Brain Stimulator (2018-2027) ($MN)
Table 31 Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Single Channel Deep Brain Stimulator (2018-2027) ($MN)
Table 32 Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Outlook, By End-user (2018-2027) ($MN)
Table 33 Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Ambulatory Surgical Centers (ASCs) (2018-2027) ($MN)
Table 34 Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Hospitals (2018-2027) ($MN)
Table 35 Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Neurology Clinics (2018-2027) ($MN)
Table 36 Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Research Centers (2018-2027) ($MN)
Table 37 South America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Country (2018-2027) ($MN)
Table 38 South America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Product (2018-2027) ($MN)
Table 39 South America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Dual Channel Deep Brain Stimulator (2018-2027) ($MN)
Table 40 South America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Single Channel Deep Brain Stimulator (2018-2027) ($MN)
Table 41 South America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By End-user (2018-2027) ($MN)
Table 42 South America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Ambulatory Surgical Centers (ASCs) (2018-2027) ($MN)
Table 43 South America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Hospitals (2018-2027) ($MN)
Table 44 South America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Neurology Clinics (2018-2027) ($MN)
Table 45 South America Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Research Centers (2018-2027) ($MN)
Table 46 Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Country (2018-2027) ($MN)
Table 47 Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Product (2018-2027) ($MN)
Table 48 Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Dual Channel Deep Brain Stimulator (2018-2027) ($MN)
Table 49 Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Single Channel Deep Brain Stimulator (2018-2027) ($MN)
Table 50 Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Outlook, By End-user (2018-2027) ($MN)
Table 51 Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Ambulatory Surgical Centers (ASCs) (2018-2027) ($MN)
Table 52 Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Hospitals (2018-2027) ($MN)
Table 53 Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Neurology Clinics (2018-2027) ($MN)
Table 54 Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Outlook, By Research Centers (2018-2027) ($MN)
Note: Product cover images may vary from those shown
3 of 4
  • Abbott
  • Aleva Neurotherapeutics SA
  • Beijing PINS Medical Co
  • Boston Scientific Corporation
  • Functional Neuromodulation Ltd.
  • Medtronic
  • Neuronetics Inc.
  • NeuroPace Inc.
  • Nevro Corporation
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll